A carregar...
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Immune checkpoint blockade (ICB) therapy provides remarkable clinical gains, where melanoma is at the forefront of its success. However, only a subset of patients with advanced tumors currently benefit from these therapies, which at times incur considerable side-effects and costs. Constructing predi...
Na minha lista:
| Publicado no: | Nat Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693632/ https://ncbi.nlm.nih.gov/pubmed/30127394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-018-0157-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|